189 related articles for article (PubMed ID: 9129043)
1. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract][Full Text] [Related]
2. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations.
Morrissey JJ; Raney S; Cleary ML
Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001
[TBL] [Abstract][Full Text] [Related]
3. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias.
Morrissey J; Tkachuk DC; Milatovich A; Francke U; Link M; Cleary ML
Blood; 1993 Mar; 81(5):1124-31. PubMed ID: 8443374
[TBL] [Abstract][Full Text] [Related]
4. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells.
Rubnitz JE; Morrissey J; Savage PA; Cleary ML
Blood; 1994 Sep; 84(6):1747-52. PubMed ID: 8080983
[TBL] [Abstract][Full Text] [Related]
5. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
[TBL] [Abstract][Full Text] [Related]
6. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
Rowley JD
Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
[TBL] [Abstract][Full Text] [Related]
7. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.
Tkachuk DC; Kohler S; Cleary ML
Cell; 1992 Nov; 71(4):691-700. PubMed ID: 1423624
[TBL] [Abstract][Full Text] [Related]
8. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
Slany RK; Lavau C; Cleary ML
Mol Cell Biol; 1998 Jan; 18(1):122-9. PubMed ID: 9418860
[TBL] [Abstract][Full Text] [Related]
9. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
[TBL] [Abstract][Full Text] [Related]
10. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
[TBL] [Abstract][Full Text] [Related]
11. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
12. MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).
Osaka M; Rowley JD; Zeleznik-Le NJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6428-33. PubMed ID: 10339604
[TBL] [Abstract][Full Text] [Related]
13. A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells.
Tse W; Zhu W; Chen HS; Cohen A
Blood; 1995 Feb; 85(3):650-6. PubMed ID: 7833468
[TBL] [Abstract][Full Text] [Related]
14. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL.
Bernard OA; Mauchauffe M; Mecucci C; Van den Berghe H; Berger R
Oncogene; 1994 Apr; 9(4):1039-45. PubMed ID: 8134107
[TBL] [Abstract][Full Text] [Related]
15. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
Zeleznik-Le NJ; Harden AM; Rowley JD
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10610-4. PubMed ID: 7938000
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 11q23 abnormalities in leukaemia.
Ridge SA; Wiedemann LM
Leuk Lymphoma; 1994 Jun; 14(1-2):11-7. PubMed ID: 7920216
[TBL] [Abstract][Full Text] [Related]
17. HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A.
Adler HT; Nallaseth FS; Walter G; Tkachuk DC
J Biol Chem; 1997 Nov; 272(45):28407-14. PubMed ID: 9353299
[TBL] [Abstract][Full Text] [Related]
18. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Hunger SP; Tkachuk DC; Amylon MD; Link MP; Carroll AJ; Welborn JL; Willman CL; Cleary ML
Blood; 1993 Jun; 81(12):3197-203. PubMed ID: 8389614
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
20. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins.
Adler HT; Chinery R; Wu DY; Kussick SJ; Payne JM; Fornace AJ; Tkachuk DC
Mol Cell Biol; 1999 Oct; 19(10):7050-60. PubMed ID: 10490642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
